Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$633,710
+$18,325 QoQ
Shares Held
1,750
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,017
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. AMGN ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $633,710 | 1,750 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $615,385 | 1,749 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $560,354 | 1,712 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $479,457 | 1,699 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $512,071 | 1,834 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $579,483 | 1,860 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $484,529 | 1,859 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $598,666 | 1,858 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $611,152 | 1,956 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $526,276 | 1,851 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $532,837 | 1,850 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $531,338 | 1,977 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $449,812 | 2,026 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $488,818 | 2,022 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $529,219 | 2,015 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $439,304 | 1,949 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $475,164 | 1,953 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $473,967 | 1,960 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $484,585 | 2,154 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $552,890 | 2,600 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $645,206 | 2,647 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $672,035 | 2,701 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $616,645 | 2,682 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $701,989 | 2,762 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $657,105 | 2,786 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $563,183 | 2,778 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||